1. Seroepidemiology of human group C rotavirus in the UK
- Author
-
S.J. Cooke, V. L. A. James, E. O. Caul, Paul R. Lambden, and Ian N. Clarke
- Subjects
biology ,viruses ,virus diseases ,Reoviridae ,biology.organism_classification ,medicine.disease_cause ,Group A ,Virology ,Virus ,law.invention ,Serology ,Infectious Diseases ,Antigen ,law ,Rotavirus ,Recombinant DNA ,medicine ,biology.protein ,Antibody - Abstract
The gene coding for the major inner capsid protein VP6 of human group C rotavirus was cloned into baculovirus using the pBlueBac2 vector and expressed in insect cells. When cultured in High Five cells, VP6 was expressed at a high level and exported to the cell culture medium. Purified VP6 was used to immunise rabbits. Hyperimmune rabbit serum, which reacted with native human group C rotavirus in infected cells, was used to develop and optimise an EIA for the detection of antibodies to group C rotavirus using the recombinant VP6 as a source of antigen. In a local epidemiological survey of 1000 sera grouped by age, an average of 43% of samples were found to have antibodies to human group C rotavirus with the highest proportion (66%) in the 71-75 year age group. In comparison, 97% of adults and 85% of children had antibodies to recombinant VP6 from the bovine RF strain of group A rotavirus. These results suggest that infection with human group C rotavirus is a common occurrence despite the apparent rarity of reports of human group C rotavirus in clinical samples from patients with gastroenteritis.
- Published
- 1997